Cytosorbents Corp - ESG Rating & Company Profile powered by AI
The webpage is a free Environmental, Social and Governance assessment for Cytosorbents Corp. This report of Cytosorbents Corp leverages data points from across the internet and also from available disclosures by Cytosorbents Corp. If you work at Cytosorbents Corp and you would like to licence your ESG aseessment, please get in touch.
Cytosorbents Corp in the Advanced Medical Equipment & Technology industry gained a UN SDG ESG Transparency Score of 3.5; made up of an environmental score of 1.6, social score of 4.0 and governance score of 4.8.
3.5
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Calmark Sweden AB | 8.0 | High |
| 1 | CHC Healthcare Group | 8.0 | High |
| ... | ... | ... | |
| 160 | Synektik SA | 3.6 | Medium |
| 160 | Theralase Technologies Inc | 3.6 | Medium |
| 166 | Cytosorbents Corp | 3.5 | Medium |
| 166 | DVx Inc | 3.5 | Medium |
| 166 | Transpact Enterprises Ltd | 3.5 | Medium |
| ... | ... | ... | |
| 260 | Zhuhai Hokai Medical Instruments Co Ltd | 0.0 | Low |
| 260 | Zynex Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Cytosorbents Corp have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Cytosorbents Corp disclose current and historical energy intensity?
Sign up for free to unlockDoes Cytosorbents Corp report the average age of the workforce?
Sign up for free to unlockDoes Cytosorbents Corp reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Cytosorbents Corp disclose its ethnicity pay gap?
Sign up for free to unlockDoes Cytosorbents Corp disclose cybersecurity risks?
Sign up for free to unlockDoes Cytosorbents Corp offer flexible work?
Sign up for free to unlockDoes Cytosorbents Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Cytosorbents Corp disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Cytosorbents Corp conduct supply chain audits?
Sign up for free to unlockDoes Cytosorbents Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Cytosorbents Corp conduct 360 degree staff reviews?
Sign up for free to unlockDoes Cytosorbents Corp disclose the individual responsible for D&I?
Sign up for free to unlockDoes Cytosorbents Corp disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Cytosorbents Corp disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Cytosorbents Corp disclose water use targets?
Sign up for free to unlockDoes Cytosorbents Corp have careers partnerships with academic institutions?
Sign up for free to unlockDid Cytosorbents Corp have a product recall in the last two years?
Sign up for free to unlockDoes Cytosorbents Corp disclose incidents of discrimination?
Sign up for free to unlockDoes Cytosorbents Corp allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Cytosorbents Corp issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Cytosorbents Corp disclose parental leave metrics?
Sign up for free to unlockDoes Cytosorbents Corp disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Cytosorbents Corp disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Cytosorbents Corp disclose the pay ratio of women to men?
Sign up for free to unlockDoes Cytosorbents Corp support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Cytosorbents Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Cytosorbents Corp reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Cytosorbents Corp involved in embryonic stem cell research?
Sign up for free to unlockDoes Cytosorbents Corp disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Cytosorbents Corp disclose its waste policy?
Sign up for free to unlockDoes Cytosorbents Corp report according to TCFD requirements?
Sign up for free to unlockDoes Cytosorbents Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Cytosorbents Corp disclose energy use targets?
Sign up for free to unlockDoes Cytosorbents Corp disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Cytosorbents Corp have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Cytosorbents Corp
These potential risks are based on the size, segment and geographies of the company.
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention and treatment of perioperative complications of cardiopulmonary bypass surgery, and maintaining or enhancing the quality of solid organs harvested from donors for organ transplant. The company also develops VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals; CytoSorb-XL, a device for adjunctive therapy in the treatment of sepsis and other critical illnesses; HemoDefend blood purification technology platform to reduce contaminants in the blood supply that can cause transfusion reactions or disease when administering blood and blood products to patients, as well as removal of anti-A and anti-B blood group antibodies from fresh whole blood and plasma; K+ontrol for treatment of severe hyperkalemia in patients with life-threatening conditions; and ContrastSorb for the removal of IV contrast in blood administered during CT imaging, an angiogram, or during a vascular interventional radiology procedure to reduce the risk of contrast-induced nephropathy. In addition, it is involved in the development of BetaSorb, a device for the prevention and treatment of health complications caused by the accumulation of metabolic toxins in patients with chronic renal failure; DrugSorb, a device to remove toxic chemicals from the blood; and DrugSorb-ATR, an antithrombotic removal system. The company was formerly known as MedaSorb Technologies Corporation and changed its name to Cytosorbents Corporation in May 2010. Cytosorbents Corporation was founded in 1997 and is headquartered in Princeton, New Jersey.